You are here

Live Biotherapeutics Drug Discovery Services for Rheumatoid Arthritis

Recent reports have shown that the gut microbiome can affect systemic immunity and promote autoimmune diseases. This provides new ideas for the treatment of rheumatoid arthritis (RA) that next-generation probiotics (NGPs) may be useful. Creative Biolabs has been devoted to the development of NGPs for years. With the comprehensive technology platform and Ph.D. level scientists, we are capable of providing global researchers with high-quality NGPs development services.